Research

NeurOptimal® is non-therapeutic and does not imply the diagnosis, treatment, mitigation of a disease, disorder or abnormal physical state or symptoms. NeurOptimal®  does not claim to restore, modify or correct  the body’s structure. Only drugs and medical devices are permitted to make such claims.

CHEMO BRAIN (Cancer Therapy)

The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy.

Postcancer cognitive impairment (PCCI) is observed in a substantial number of breast cancer survivors, persisting for as long as 20 years in some subgroups. Although compensatory strategies are frequently suggested, no restorative interventions have yet been identified.

 

This study examined the feasibility of EEG biofeedback (“neurofeedback”) and its potential effectiveness in reducing PCCI as well as the fatigue, sleep disturbance, and psychological symptoms that frequently accompany PCCI.